Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
    September 2022
  1. ANDO T, Hosokawa A, Sakumura M, Motoo I, et al
    Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer.
    Oncology. 2022 Sep 14. pii: 000526577. doi: 10.1159/000526577.
    >> Share

  2. NAKAZAWA N, Sohda M, Ide M, Shimoda Y, et al
    PROX1 was associated with LGR5 and Wnt signaling and contributed to poor prognosis in gastric cancer.
    Oncology. 2022 Sep 14. pii: 000526734. doi: 10.1159/000526734.
    >> Share

    March 2022
  3. MIURA S, Wakahara T, Yamauchi S, Yasuhara Y, et al
    The Amount and Concentration of Drain Amylase Together Predict Postoperative Pancreatic Fistula after Gastric Cancer Surgery More Accurately than the Concentration Alone.
    Oncology. 2022 Mar 25. pii: 000524301. doi: 10.1159/000524301.
    >> Share

    January 2022
  4. ALLAW MB, Switchenko JM, Khalil L, Wu C, et al
    Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
    Oncology. 2022;100:131-139.
    >> Share

  5. ROGERS JE, Wang X, Trail A, Ajani JA, et al
    Beyond Front-Line Therapy for Unresectable Gastroesophageal Adenocarcinoma: Are There Differences in Subsequent Therapy Sequencing?
    Oncology. 2022;100:182-187.
    >> Share

    August 2021
  6. NAKAZAWA N, Sohda M, Ide M, Shimoda Y, et al
    High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients.
    Oncology. 2021 Aug 13:1-8. doi: 10.1159/000517371.
    >> Share

    July 2021
  7. TOKUMARU S, Koizumi T, Sekino Y, Takeuchi N, et al
    Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
    Oncology. 2021 Jul 19:1-9. doi: 10.1159/000517344.
    >> Share

    March 2021
  8. OKUBO K, Arigami T, Matsushita D, Tanaka T, et al
    Clinical Impact of the Prognostic Nutritional Index as a Predictor of Outcomes in Patients with Stage II/III Gastric Cancer: A Retrospective Cohort Study.
    Oncology. 2021 Mar 5:1-9. doi: 10.1159/000514572.
    >> Share

    January 2021
  9. JIANG DM, Sim HW, Espin-Garcia O, Chan BA, et al
    Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
    Oncology. 2021;99:49-56.
    >> Share

  10. NAMIKAWA T, Maeda M, Yokota K, Iwabu J, et al
    Enteral Vitamin B12 Supplementation Is Effective for Improving Anemia in Patients Who Underwent Total Gastrectomy.
    Oncology. 2021;99:225-233.
    >> Share

  11. ABDELHAKEEM A, Patnana M, Wang X, Rogers JE, et al
    Influence of Baseline Positron Emission Tomography in Metastatic Gastroesophageal Cancer on Survival and Response to Therapy.
    Oncology. 2021;99:659-664.
    >> Share

    October 2020
  12. UBUKATA Y, Ogata K, Sohda M, Yokobori T, et al
    Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
    Oncology. 2020 Oct 28:1-8. doi: 10.1159/000509033.
    >> Share

    September 2020
  13. ARIGAMI T, Matsushita D, Okubo K, Sasaki K, et al
    Clinical Significance of Conversion Surgery for Gastric Cancer with Peritoneal Dissemination: A Retrospective Study.
    Oncology. 2020 Sep 9:1-9. doi: 10.1159/000509530.
    >> Share

  14. NAKAMURA M, Ojima T, Katsuda M, Hayata K, et al
    Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
    Oncology. 2020 Sep 2:1-5. doi: 10.1159/000509396.
    >> Share

    June 2020
  15. ZHOU J, Zhao Z, Zhang Y, Bao C, et al
    Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
    Oncology. 2020 Jun 10:1-6. doi: 10.1159/000505664.
    >> Share

    May 2020
  16. AHOPELTO K, Laitinen A, Hagstrom J, Bockelman C, et al
    Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
    Oncology. 2020 May 20:1-10. doi: 10.1159/000507350.
    >> Share

  17. ARIGAMI T, Matsushita D, Okubo K, Yanagita S, et al
    Response Rate and Prognostic Impact of Salvage Chemotherapy after Nivolumab in Patients with Advanced Gastric Cancer.
    Oncology. 2020 May 19:1-7. doi: 10.1159/000507219.
    >> Share

  18. ITO S, Masuda T, Noda M, Hu Q, et al
    Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
    Oncology. 2020 May 7:1-11. doi: 10.1159/000506075.
    >> Share

    April 2020
  19. DI PINTO F, Armentano R, Arborea G, Schena N, et al
    Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
    Oncology. 2020 Apr 21:1-9. doi: 10.1159/000506077.
    >> Share

    March 2020
  20. NAMIKAWA T, Yokota K, Yamaguchi S, Iwabu J, et al
    Evaluation of Systemic Inflammatory Response and Nutritional Biomarkers as Predictive Factors in Patients with Recurrent Gastric Cancer.
    Oncology. 2020 Mar 17:1-8. doi: 10.1159/000505973.
    >> Share

    February 2020
  21. ARIGAMI T, Matsushita D, Okubo K, Kawasaki Y, et al
    Indication and Prognostic Significance of Conversion Surgery in Patients with Liver Metastasis from Gastric Cancer.
    Oncology. 2020 Feb 14:1-7. doi: 10.1159/000505555.
    >> Share

    January 2020
  22. WAKAHARA T, Kanemitsu K, Asari S, Tsuchida S, et al
    The Combined Use of Drainage Amylase Concentration and Serum C-reactive Protein as Predictors of Pancreas-Related Complications after Elective Gastrectomy.
    Oncology. 2020;98:111-116.
    >> Share

  23. ROGERS JE, Xiao L, Trail A, Blum Murphy M, et al
    Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer.
    Oncology. 2020;98:289-294.
    >> Share

  24. MIZRAK KAYA D, Nogueras Gonzalez GM, Harada K, Blum Murphy MA, et al
    Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma.
    Oncology. 2020;98:542-548.
    >> Share

  25. WUNDSAM HV, Doleschal B, Prommer R, Venhoda C, et al
    Clinical Outcome in Patients with Carcinoma of the Esophagogastric Junction Treated with Neoadjuvant Radiochemotherapy or Perioperative Chemotherapy: A Two-Center Retrospective Analysis.
    Oncology. 2020;98:706-713.
    >> Share

  26. ABDELHAKEEM A, Wang X, Rogers JE, Trail A, et al
    Outcomes of Advanced Gastroesophageal Cancer Patients with Equivocal HER2 Expression with or without ERBB2 Gene Amplification.
    Oncology. 2020;98:884-888.
    >> Share

    September 2019
  27. JUNG DH, Bae YJ, Kim JH, Shin YK, et al
    HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells.
    Oncology. 2019 Sep 24:1-8. doi: 10.1159/000502845.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016